Cargando…
Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
INTRODUCTION: Supplemental oxygen is the most important treatment for preterm born infants with established bronchopulmonary dysplasia (BPD). However, it is unknown what oxygen saturation levels are optimal to improve outcomes in infants with established BPD from 36 weeks postmenstrual age (PMA) onw...
Autores principales: | Balink, Stephanie, Onland, Wes, Vrijlandt, Elianne J L E, Andrinopoulou, Eleni-Rosalina, Bos, Arend F, Dijk, Peter H, Goossens, Lucas, Hulsmann, Anthon R, Nuytemans, Debbie H, Reiss, Irwin K M, Sprij, Arwen J, Kroon, André A, van Kaam, Anton H, Pijnenburg, Marielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272124/ https://www.ncbi.nlm.nih.gov/pubmed/35803625 http://dx.doi.org/10.1136/bmjopen-2022-060986 |
Ejemplares similares
-
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
por: Onland, Wes, et al.
Publicado: (2018) -
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
por: Onland, Wes, et al.
Publicado: (2011) -
Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic
por: Ruran, Hana B, et al.
Publicado: (2021) -
The association between clinical and biochemical characteristics of late-onset sepsis and bronchopulmonary dysplasia in preterm infants
por: Ebrahimi, Melania E., et al.
Publicado: (2021) -
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019)